We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Supplement Presents Studies on Importance of Simpler Diagnostics for Infectious Diseases

By LabMedica International staff writers
Posted on 07 Dec 2015
The Diagnostics Modelling Consortium (DMC) and the Gates Foundation have published a supplement of papers on their latest research outcomes across a range of infectious diseases that affect developing world countries, emphasizing that improved, well-considered field diagnostics could support elimination of multiple diseases. More...
Studies included the use of mathematical modeling to predict impact of new diagnostic tools.

One of the studies, led by researchers from Imperial College London (London, UK), found that wider use of the pulse oximeter (the finger-clip device that measures blood oxygen and pulse) could prevent 148,000 pneumonia deaths in the under-fives in countries where the disease is most prominent. "This is a very simple tool that could have a very big impact," said paper senior author Prof. Azra Ghani, Imperial's School of Public Health and director of the DMC.

Routinely used in hospitals, pulse oximetry is a simple, noninvasive technology that can help diagnose conditions, such as pneumonia, that trigger low oxygen levels. The device is not routinely available in community settings, where pneumonia is often diagnosed via counting the number of breaths per minute, and observing whether a child is sucking their chest under the rib cage, suggesting a struggle to breathe. The researchers argue that pulse oximetry could allow children to be more quickly diagnosed and sent to hospital for life-saving oxygen and antibiotics. However, they caution, improvement also depends on having access to a nearby hospital or medical facility.

In another paper, researchers call for investment to improve diagnostic screening tools for detection of people who are infected but asymptomatic. For example, current tests for malaria, which involve blood finger-prick sampling, can identify only about 50% of carriers, from whom infection can be transmitted further. Detecting a 10-fold lower density of parasites in blood could increase detection rate to over 80%. “Increasing the sensitivity of these tests could improve the prospect of malaria elimination,” said Dr. Hannah Slater, Imperial’s School of Public Health and lead author of one of the malaria papers. With recent investment from the UK government and the Bill and Melinda Gates Foundation it is hoped that malaria could be eradicated in the next 30 years.

Another paper calls for expanded use and improvement of rapid diagnostic tests for Ebola. In the recent outbreak, Ebola testing took 2–7 days, during which patients remained in a holding area where infected and uninfected patients stayed together until their results came in, increasing the risk of contracting Ebola and taking up limited bed capacity. The authors calculated that if rapid tests had been available and used from the start, the scale of the outbreak could have reduced by a third. “The availability of a rapid diagnostic test could have had a dramatic impact on the epidemic and is therefore a priority for future investment, said lead author Dr. Pierre Nouvellet, Imperial’s School of Public Health.

Other papers in the supplement explore similar issues for HIV, TB, or neglected tropical diseases. "Developing effective tests to diagnose disease is critical to guide use of other interventions, such as drugs and vaccines," said Prof. Ghani, “They therefore have the potential to save lives by directing resources to those most in need.”

The supplement was published December 3, 2015, in the journal Nature under contractual agreement with and funding by the Bill and Melinda Gates Foundation and. Content was not written or reviewed by Nature editors.

Related Links:

Imperial College London
Supplement: Infectious disease control and elimination - Modelling the impact of improved diagnostics 



Gold Member
Serological Pipets
INTEGRA Serological Pipets
Portable Electronic Pipette
Mini 96
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.